Anti-vascular endothelial growth factor in neovascular age-related macular degeneration - a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems

Finger R. P., Daien V., Eldem B. M., Talks J. S., Korobelnik J., Mitchell P., ...More

BMC OPHTHALMOLOGY, vol.20, no.1, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Review
  • Volume: 20 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.1186/s12886-020-01554-2
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE, Directory of Open Access Journals
  • Hacettepe University Affiliated: Yes


Background: Systematically review the evidence describing the impact of anti-vascular endothelial growth factor (anti-VEGF) therapy on neovascular age-related macular degeneration (nAMD) patient outcomes and healthcare resource utilization.